gsk news - Search News

GSK, IDRx and Biotechnology

GSK Nears $1 Billion Deal for Biotech Company IDRx

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio.

pharmaphorum · 9h

Is GSK prepping a $1bn takeover bid for IDRx?

GSK is reportedly in late-stage negotiations about a $1 billion deal to acquire IDRx and its experimental targeted therapy for a form of rare gastrointestinal stromal tumour (GIST).

Business Insider · 1d

GSK in advanced talks to purchase U.S. biotech IDRx, FT reports

GSK (GSK) is in advanced discussions to purchase privately-owned U.S. biotech IDRx, which is working on a treatment for rare gastrointestinal

Hosted on MSN · 1d

GSK is said to be nearing $1B deal to acquire U.S. biotech IDRx

British pharma giant GSK (NYSE:GSK) is closing in on a $1B buyout deal to acquire IDRx, a U.S. biotech focused on developing drugs for rare gastrointestinal tumors, The Financial Times reported Wednesday.

GSK, Pfizer and RSV

Fortune · 19h

GSK, Pfizer RSV shots must warn about rare paralysis risk

Barré for every million doses given.

Reuters · 1d

GSK and Pfizer's RSV vaccines to carry warnings of neurological disorder risk

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on Tuesday.

FiercePharma · 1d

RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare neurological condition that can cause paralysis.

GSK falls Thursday, underperforms market

Shares of GSK PLC GSK inched down 0.77% to £13.50 Thursday, on what proved to be an all-around positive trading session for ...

Hosted on MSN2d

GSK's ADC Drug Gets FDA's Breakthrough Tag for Rare Bone Cancer

GSK plc GSK announced that the FDA has granted a Breakthrough Therapy Designation to its investigational B7-H3-targeted ...

GSK’s GSK’227 receives FDA BTD for treating adults with relapsed osteosarcoma

GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for GSK5764227, GSK’227, ...

GSK rises Wednesday, outperforms market

GSK PLC GSK shares inched up 0.18% to £13.60 Wednesday, on what proved to be an all-around favorable trading session for the ...

3don MSN

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at ...

Bernstein Remains a Buy on GlaxoSmithKline (GSK)

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Boltwood Capital Management Raises Holdings in GSK plc (NYSE:GSK)

Boltwood Capital Management lifted its stake in GSK plc (NYSE:GSK – Free Report) by 9.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund ...

Hosted on MSN3d

China’s NMPA approves GSK’s Nucala for CRSwNP treatment

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

GSK, IDRx and Biotechnology

GSK, Pfizer and RSV

Related topics